The Medication Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Asians: The Major Drug Causality and Comparison to the USA FDA Label Yu-Hsin Wang 1,2 , *Chun-Bing Chen 1,2,3,4,22 , Wichittra Tassaneeyakul 5 , Yoshiro Saito 6 , Michiko Aihara 7 , Siew Eng Choon 8 , Haur Yueh Lee 9.10 , Mimi Mee Chang 11 , Francisca D. Roa 12 , Cheng-Wei Wu 13 , Jing Zhang 14 , Nontaya Nakkam 5 , Parinya Konyoung 15 , Yoshimi Okamoto-Uchida 6 , Christina Man-tung Cheung 11 , Jin-wen Huang 14 , Chao Ji 14 , Bo Cheng 14 , Rosaline Chung-Yee Hui 1,2,3 , Chia-Yu Chu 16 , Yi-Ju Chen 17 , Ching-Ying Wu 18 , Chao-Kai Hsu 19 , Tsu-Man Chiu 20 , Hsin-Chun Ho 1,2,3 , Jing- Yi Lin 1,2,3 , Chih-Hsun Yang 1,2,3 , Ya-Ching Chang 1,2,3 , Shih-Chi Su 1,2,21 , Chuang Wei Wang 1,2,21 ,Wen-Hung Chung 1,2,3,4,21,22,23 ; for the Asian Severe Cutaneous Adverse Reaction Consortium. * The contributions of Chun-Bing Chen were equal to those of the first author. 1 Chang Gung Memorial Hospital, Linkou, Taiwan 2 Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Taipei, Linkou, and Keelung, Taiwan 3 College of Medicine, Chang Gung University, Taoyuan, Taiwan 4 Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan 5 Department of Pharmacology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand 6 Division of Medicinal Safety Science, National Institute of Health Sciences, Japan 7 Department of Environmental Immuno-Dermatology, Yokohama City University This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process which may lead to differences between this version and the Version of Record. Please cite this article as an ‘Accepted Article’, doi: 10.1002/cpt.1071 This article is protected by copyright. All rights reserved.